Corneal Nerve Structure in Sjogren's
NCT03203382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-08-04
Summary
Patients who are suspected of or diagnosed with Sjogren's disease will be evaluated for ocular symptoms and corneal nerve morphology. We are specifically interested in the relationship between Vitamin D level and aberrations in the morphology of the corneal nerves.
Conditions
- Sjogren's Syndrome
- Vitamin D Deficiency
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Giacomina Massaro-Giordano · Scheie Eye Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2017-04-30
- Completion
- 2017-04-30
Countries
- United States
Study Locations
More Related Trials
-
Natural History, Pathogenesis, and Outcome of Ocular Disorders
NCT02821767 ·Status: RECRUITING
-
Genetic Factors in Age-Related Macular Degeneration
NCT00058695 ·Status: TERMINATED
-
Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
NCT00060749 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
NCT00004345 ·Status: TERMINATED
-
Genetic Association of Diabetic Retinopathy-1
NCT01298245 ·Status: UNKNOWN
-
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
NCT00346333 ·Status: COMPLETED ·Phase: PHASE3
-
Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations
NCT07265895 ·Status: NOT_YET_RECRUITING
-
BIOtinidase Test In Optic-Neuropathy
NCT03268681 ·Status: COMPLETED
-
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
NCT06445322 ·Status: RECRUITING
-
Age-related Macular Degeneration (AMD) and Cardiovascular Disease
NCT04087356 ·Status: UNKNOWN
-
Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa
NCT00065455 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Systemic Light Chain Amyloidosis on Eyes
NCT06803082 ·Status: RECRUITING
-
Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma
NCT02539745 ·Status: COMPLETED
-
Vitamin D Levels in Patients With Central Retinal Vein Occlusion- a Prospective Controlled Study
NCT01793181 ·Status: COMPLETED
-
CNGB1 and Allied Disorders
NCT04639635 ·Status: SUSPENDED
-
Macular Pigment Measurements in Eye & Other Tissues
NCT03022773 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Gyrate Atrophy of the Choroid and Retina
NCT00001166 ·Status: COMPLETED
-
Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A
NCT00000116 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)
NCT02926092 ·Status: TERMINATED
-
Dietary Riboflavin (Vitamin B-2) and Cornea Cross-Linking
NCT03095235 ·Status: TERMINATED ·Phase: NA
-
The Zeaxanthin and Visual Function Study
NCT00564902 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa
NCT00000114 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Lutein in Retinitis Pigmentosa
NCT00029289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nitisinone for Type 1B Oculocutaneous Albinism
NCT01838655 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of Macular Pigment in Patients With Age-related Macular Degeneration
NCT00494325 ·Status: COMPLETED